USCareCheck

CMS certification 103301

Nicklaus Children's Hospital

3100 SW 62nd Ave, Miami, FL 33155

Childrens Emergency services

This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.

CMS overall rating Not rated Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.
Would definitely recommend No survey results published
Patient survey rating Not rated HCAHPS patient survey
Compared with the nation Too few cases for CMS to compare

What patients said

Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.

Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.

Not reported for this hospital

CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.

Clinicians registered at this address

736 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 160 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.

Specialty Clinicians
Pediatrics 185
Family 80
Pediatric Emergency Medicine 60
Physician Assistant 28
Pediatric Cardiology 23
Pediatric Critical Care Medicine 23
Nurse Practitioner 19
Pediatric Radiology 19
Dietitian, Registered 17
Pediatric Anesthesiology 16
Pediatric Endocrinology 12
Pediatric Gastroenterology 11

First 12 alphabetically

Money from drug and device companies

Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.

2025 total $935,117 general $52,825 · research $882,292
All years, 2019–2025 $6.4M 1,610 reported payments
Studies funded, 2025 40 35 companies paid in total
  • 2019 $1.1M
  • 2020 $1.6M
  • 2021 $883,398
  • 2022 $581,549
  • 2023 $811,523
  • 2024 $619,484
  • 2025 $935,117

General payments Research payments

What the 2025 general payments were for

Type of payment Amount Payments
Space rental and facility fees $21,297 4
Debt forgiveness $16,094 4
Medical devices and supplies on long-term loan $12,307 23
Speaking, teaching and other services $3,085 5
Education $43 1

Largest paying companies, 2025

Company Amount Payments
Ultragenyx Pharmaceutical Inc. $264,280 10
Ucb Sa $133,752 4
Merit Medical Systems Inc $69,521 15
Hoffmann-La Roche Limited $63,838 23
BioMarin Pharmaceutical Inc. $45,608 4
H. Lundbeck A S $43,197 6
Pfizer INC. $28,249 7
Eli Lilly and Company $24,925 1

Largest research studies funded here, 2025

Study Amount
GTX-102-CL301 Ultragenyx Pharmaceutical Inc. · NCT06617429 $264,280
PREEMIE: Study for Treatment of PDA in Premature Infants Merit Medical Systems Inc $69,521
Efficacy Safety of Obinutuzumab vs MMF in patients with idiopathic nephrotic syndrome Hoffmann-La Roche Limited $63,483
A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study with a 2-Stage Adaptive Design and Ra… UCB SA · NCT04666610 $49,672
MULTICENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO-CONTROLLED (12 17 YEARS) INCLUDING A SINGLE OPEN LABEL ARM (6 11 YEARS) STUDY TO EVALU… UCB SA · NCT04123795 $30,860
A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH … UCB SA · NCT04519645 $29,582
A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY EVALUATING ABEMACICLIB IN COMBINATION WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE MONOTHERAPY IN CHILDREN AND … Eli Lilly and Company · NCT06413706 $24,925
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia ModernaTX, Inc. · NCT04159103 $23,639

Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.

How to read this page

  • Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
  • “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
  • Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
  • Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
  • These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.

CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error

Common questions about Nicklaus Children's Hospital

Does Nicklaus Children's Hospital have an emergency room?

Yes. CMS lists emergency services at Nicklaus Children's Hospital.

Does Nicklaus Children's Hospital receive money from drug and device companies?

Drug and device makers reported $935,117 in payments to Nicklaus Children's Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.